Combination of docetaxel versus nonsteroidal antiandrogen with androgen deprivation therapy for high-volume metastatic hormone-sensitive prostate cancer: a propensity score-matched analysis

PURPOSE: The aim of this study was to investigate the oncologic efficacy of combining docetaxel with androgen deprivation therapy (ADT) versus nonsteroidal antiandrogen (NSAA) with ADT in patients with high-volume metastatic hormone-sensitive prostate cancer (mHSPC) with focus on the effect of seque...

Descripción completa

Detalles Bibliográficos
Autores principales: Yanagisawa, Takafumi, Kimura, Takahiro, Hata, Kenichi, Narita, Shintaro, Hatakeyama, Shingo, Mori, Keiichiro, Sano, Takayuki, Otsuka, Takashi, Iwamoto, Yuya, Enei, Yuki, Nakazono, Minoru, Sakanaka, Keigo, Iwatani, Kosuke, Matsukawa, Akihiro, Atsuta, Mahito, Nishikawa, Hideomi, Tsuzuki, Shunsuke, Miki, Jun, Habuchi, Tomonori, Ohyama, Chikara, Shariat, Shahrokh F., Egawa, Shin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Topic Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10415473/
https://www.ncbi.nlm.nih.gov/pubmed/35596809
http://dx.doi.org/10.1007/s00345-022-04030-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10415473/
https://www.ncbi.nlm.nih.gov/pubmed/35596809
http://dx.doi.org/10.1007/s00345-022-04030-2

Ejemplares similares